Optinose to Present at the Needham Virtual Healthcare Conference
Optinose (NASDAQ:OPTN) announced that CEO Peter Miller will present a company overview and update at the Needham Virtual Healthcare Conference on April 15, 2021, at 11:45 a.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Optinose (NASDAQ:OPTN) announced that CEO Peter Miller will present a company overview and update at the Needham Virtual Healthcare Conference on April 15, 2021, at 11:45 a.m. ET. The presentation will be available for live streaming on the Optinose Investors page. A recorded version of the webcast will be accessible for 30 days post-event. As a global specialty pharmaceutical company, Optinose focuses on ENT and allergy treatments. For more details about Optinose and their offerings, visit their official website or follow them on social media.
Details
News Market Reaction – OPTN
The recorded move for OPTN in the trading session of this news was +2.31%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
YARDLEY, Pa., April 12, 2021 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that Chief Executive Officer Peter Miller will present a company overview and business update at the Needham Virtual Healthcare Conference on April 15, 2021, at 11:45 a.m. ET.
To listen to a webcast of the presentation live, please visit the Investors page of the Optinose website.
A replay of the webcast will be available for 30 days following the conclusion of the event.
About Optinose
Optinose is a global specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. To learn more, please visit www.optinose.com or follow us on Twitter and LinkedIn.
Optinose Investor Contact
Jonathan Neely
jonathan.neely@optinose.com
267.521.0531
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.